Cargando…
The Anterior Eye Chamber as a Visible Medium for In Vivo Tumorigenicity Tests
Pluripotent stem cell (PSC)-based cell therapies have increased steadily over the past few years, and assessing the risk of tumor formation is a high priority for clinical studies. Current in vivo tumorigenesis studies require several months and depend strongly on the site of grafting. In this study...
Autores principales: | Inagaki, Emi, Arai, Eri, Hatou, Shin, Sayano, Tomoko, Taniguchi, Hiroko, Negishi, Kazuno, Kanai, Yae, Sato, Yasunori, Okano, Hideyuki, Tsubota, Kazuo, Shimmura, Shigeto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397653/ https://www.ncbi.nlm.nih.gov/pubmed/35666752 http://dx.doi.org/10.1093/stcltm/szac036 |
Ejemplares similares
-
Non-apoptotic regulated cell death in Fuchs endothelial corneal dystrophy
por: Sakakura, Saki, et al.
Publicado: (2023) -
Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell‐Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury
por: Kojima, Kota, et al.
Publicado: (2018) -
Long-term homeostasis and wound healing in an in vitro epithelial stem cell niche model
por: Miyashita, Hideyuki, et al.
Publicado: (2017) -
The Semaphorin 3A inhibitor SM-345431 preserves corneal nerve and epithelial integrity in a murine dry eye model
por: Yamazaki, Risa, et al.
Publicado: (2017) -
Skin‐Derived Precursors as a Source of Progenitors for Corneal Endothelial Regeneration
por: Inagaki, Emi, et al.
Publicado: (2017)